🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: The mainstay of therapy for newly diagnosed multiple myeloma p...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2001-02-08
Trial ID
NCT00006184
This phase IIa trial compares the safety and effect of temozolomide combine...
Status
Suspended
Location
Roswell Park Cancer Institute
Start Date
2026-10-15
Trial ID
NCT06202066
This was a Phase II, randomized, open-label, multicenter study designed to ...
Status
Completed
Location
Univ of Alabama at Birmingham
Start Date
2006-01-23
Trial ID
NCT00282308
This study is being done to determine whether it is possible to use an inve...
Status
Terminated
Location
Universtiy of Michigan Comprehensive Cancer Center
Start Date
2006-10
Trial ID
NCT00843830
Treatments Being Tested
The primary objectives of this study were: to evaluate the effect of Tysabr...
Status
Completed
Location
Research Site 1
Start Date
2008-01
Trial ID
NCT00536120
Treatments Being Tested
First-in-human, phase I, randomized, double-blind, placebo-controlled, sing...
Status
Completed
Location
SGS Antwerpen
Start Date
2015-04
Trial ID
NCT02800811
Atopic dermatitis (AD) is a skin disorder in which people often have swelli...
Status
Completed
Location
National Jewish Health
Start Date
2007-12
Trial ID
NCT00614731
Treatments Being Tested
The purpose of this research study is to find out whether adding an experim...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2011-12
Trial ID
NCT01498328
Treatments Being Tested
The purpose of this study is to determine the safety of using a treatment c...
Status
Terminated
Location
Morristown Memorial Hospital
Start Date
2004-10
Trial ID
NCT00265603
Treatments Being Tested
Newly diagnosed glioblastoma (GBM) patients with complete or partial surgic...
Status
Terminated
Location
The Preston Robert Tisch Brain Tumor Center at Duke
Start Date
2016-12-07
Trial ID
NCT02864368